Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Antihypertensive Deprescribing in Long-term Care: A Randomized Controlled Trial (OptimizeBP)

Authors not listed

University of Alberta · 2021

Abstract

Frail older adults are commonly prescribed blood pressure medication, yet it is unclear if blood pressure medication is actually beneficial for them. Observational studies in this population suggest blood pressure medication has limited benefit and may even be harmful, including an increased risk for falls and cognitive impairment. Randomized controlled trials are needed to confirm this. This study is a randomized controlled trial of blood pressure medication deprescribing, amongst long-term care residents with systolic blood pressure lower than 135 mmHg. In the intervention group, with physician consent, the facility pharmacist or nurse practitioner will continually reduce antihypertensives provided an upper systolic threshold of 145 mmHg is not exceeded. The control group will receive usual care. The hypothesis is that avoiding unnecessarily low systolic blood pressure is beneficial in a frail, end-of-life population.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
Anonymous. (2021). Antihypertensive Deprescribing in Long-term Care: A Randomized Controlled Trial (OptimizeBP). <em>University of Alberta</em>. https://clinicaltrials.gov/study/NCT05047731
Vancouver
Anonymous. Antihypertensive Deprescribing in Long-term Care: A Randomized Controlled Trial (OptimizeBP). University of Alberta. 2021.
BibTeX
@misc{anon2021Antihy, title = {Antihypertensive Deprescribing in Long-term Care: A Randomized Controlled Trial (OptimizeBP)}, author = {Anonymous}, journal = {University of Alberta}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings